Intralymphatic allergen-specific immunotherapy: an effective and safe alternative treatment route for pollen-induced allergic rhinitis.
about
Allergen Immunotherapy: Past, Present, and FutureAllergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific ImmunotherapyAllergen-specific immunotherapy: is it vaccination against toxins after all?Basic science for the clinician: Mechanisms of sublingual and subcutaneous immunotherapy.A Pilot Study of Intralymphatic Immunotherapy for House Dust Mite, Cat, and Dog Allergies.Allergen-encoding bone marrow transfer inactivates allergic T cell responses, alleviating airway inflammation.Intradermal grass pollen immunotherapy increases TH2 and IgE responses and worsens respiratory allergic symptoms.Food allergy diagnosis and therapy: where are we now?Intralymphatic immunotherapyIntralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial.Intralymphatic immunotherapy induces allergen specific plasmablasts and increases tolerance to skin prick testing in a pilot study.Mechanisms of immune tolerance to allergens in childrenEmerging therapies for food allergy.New directions in immunotherapy.New approaches to transcutaneous immunotherapy: targeting dendritic cells with novel allergen conjugates.Investigational drugs for the treatment of allergic rhinitis.Updating the role played by immunotherapy for allergic rhinitis: meta-analysis.Current developments for improving efficacy of allergy vaccines.Grass pollen immunotherapy: where are we now.Allergen immunotherapy for birch pollen-allergic patients: recent advances.Novel strategies for the treatment of grass pollen-induced allergic rhinitis.Allergen immunotherapy: routes, safety, efficacy, and mode of action.Novel approaches and perspectives in allergen immunotherapy.Investigational new drugs for allergic rhinitis.In vivo reprogramming of immune cells: Technologies for induction of antigen-specific tolerance.Allergen-specific intralymphatic immunotherapy in human and animal studies.Is The Allergen Really Needed in Allergy Immunotherapy?Conference Scene: novelties in immunotherapy.Re-educating immunity in respiratory allergies: the potential for hematopoietic stem cell-mediated gene therapy.Therapeutic vaccines for allergic disease.Next generation immunotherapy for tree pollen allergies.Long-term effects of intralymphatic immunotherapy (ILIT) on canine atopic dermatitis.A double blind, randomized, placebo controlled trial of the efficacy, quality of life and safety of food allergen-specific sublingual immunotherapy in client owned dogs with adverse food reactions: a small pilot study.
P2860
Q26765974-A940F061-FAC5-4C2E-8A35-B6DE13251DEBQ26852113-26876738-D1E4-4AD5-AC94-E488D88D10C5Q30248317-7998E821-D778-47E4-B9D1-07F53AD94257Q30276174-0EA6F1AD-BD36-4488-B66B-A3CB6C9F5CA4Q30357448-35C37794-E486-4C18-9F26-AADFF2E01EBBQ33752348-BD8DEBF6-9AC9-48F2-B5E9-177500860B9DQ33758296-4372A9C9-6B57-42D3-8417-BD9BE51D8599Q34000536-DE60AFB1-C8B9-4CCF-8D12-DE3EDB9A2E56Q35155423-C06CB834-3109-4B8B-9B31-2CA04D412EE8Q36507987-7DB7A5A9-AA91-42EC-A167-ECDD55BD7916Q36937180-EFD57772-1AE4-41C0-9290-F150655114BAQ37453510-09AFC4B4-5ABA-4087-A068-40B01DCDFD8FQ37726651-83243752-3621-402B-AB44-A4C9394A6927Q38073718-70FC000E-3AA3-4E18-917E-8D5FF7FCACE5Q38156306-36F320C0-DA65-4D42-BC70-AB9C38FC9D61Q38202695-E4E57B41-05B5-4B22-96E3-BB5446B731ABQ38271427-FCF3258E-DCCA-412C-BB0B-BABB1745DF40Q38503330-1D9A5F99-B15B-4120-A2FD-127CBF4454ABQ38773340-4601AE02-87D2-4B2A-A1A1-FC454FD9E8FEQ38824177-76A22A5B-4E35-4CB2-8A76-33AB822321F2Q38857421-FF71DEEB-F089-404B-845B-7B152D81E518Q38912244-0DB39506-F1CA-4B55-A7F7-DD853AA72F55Q39103046-76F5CD0A-F87A-45B8-8B1B-490EEC261480Q39111947-3AE9D39B-1915-40EB-8DEF-2C3D0858D623Q39245827-AF71F336-B3C5-42A1-9147-D8AF1D06A7B5Q41190519-2905EB23-8D91-4634-9A29-DEF8C870D8E3Q42730811-15D1AF37-3E7D-40BE-AB40-A48ABE9C2E38Q45160730-297D6954-6C18-4E65-86BC-2E003F9360B9Q45874675-2E4B9B89-B74F-40F9-9F24-F43222690924Q47100584-4FACCDA6-1A72-4BBF-8839-2A647B2A8775Q47884083-C1D03986-0954-4844-98D3-DC7596C324D5Q48255235-9A619316-9415-45EC-92FE-34347BD4E2DEQ49035795-7E5F97A3-D3D0-4E08-8898-BA3900A43955
P2860
Intralymphatic allergen-specific immunotherapy: an effective and safe alternative treatment route for pollen-induced allergic rhinitis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Intralymphatic allergen-specif ...... len-induced allergic rhinitis.
@en
Intralymphatic allergen-specif ...... len-induced allergic rhinitis.
@nl
type
label
Intralymphatic allergen-specif ...... len-induced allergic rhinitis.
@en
Intralymphatic allergen-specif ...... len-induced allergic rhinitis.
@nl
prefLabel
Intralymphatic allergen-specif ...... len-induced allergic rhinitis.
@en
Intralymphatic allergen-specif ...... len-induced allergic rhinitis.
@nl
P2093
P1476
Intralymphatic allergen-specif ...... len-induced allergic rhinitis.
@en
P2093
Lars Olaf Cardell
Leith Latif
Terese Hylander
Ulla Petersson-Westin
P304
P356
10.1016/J.JACI.2012.10.056
P407
P577
2013-02-01T00:00:00Z